DUBLIN, Ireland and CAMBRIDGE, Mass., March 04, 2020 (GLOBE NEWSWIRE) -- Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome ...

Children get sick and injured no matter how well adults protect them. It's natural to want to ease their discomfort when they're not feeling well. Acetaminophen, commonly known by the brand name ...

March 12, 2008 — Life-threatening adverse events and death have been reported in patients receiving incorrect doses of hydrocodone plus chlorpheniramine extended-release suspension (Tussionex ...

Duke Medicine is part of a groundbreaking initiative to reduce the risk and dangers faced everyday by millions of children who are prescribed medications that lack definitive data about pediatric ...

The saying “children are not small adults” is true in many respects, including its application to the treatment of children’s medical disorders with over-the-counter and prescription medicines. It is ...

Clearmind Medicine Inc. announced a significant achievement as the first participant has been dosed with its proprietary oral drug candidate, CMND-100, in a Phase I/IIa clinical trial aimed at ...

Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and reduce side effects. LONDON, September 18, 2025--(BUSINESS WIRE)--Closed Loop Medicine Ltd (CLM), a leader ...

Vancouver, Canada, Dec. 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel ...

Vancouver, Canada, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and ...